Colon Cancer Clinical Trial
Official title:
Open Study to Assess the Tolerability, Safety and Efficacy of an Adapted 2 Litre Gut Cleansing Solution (NRL0706) in Routine Colon Cleansing Prior to Colonoscopies for Colon Tumour Screening.
Verified date | November 2010 |
Source | Norgine |
Contact | n/a |
Is FDA regulated | No |
Health authority | Germany: Ministry of Health |
Study type | Interventional |
It is particularly important that thorough gut cleansing is achieved prior to the
colonoscopy for the procedure to be successful. Polyethylene glycol plus electrolyte (PEG+E)
solutions are well established as safe and effective agents for gut cleansing and Norgine
has successfully developed a low volume (2 litre) PEG+E gut lavage solution. The efficacy
and safety of this solution is similar to the standard 4 litre PEG+E, but with improved
patient acceptance.
Tolerance, acceptability and satisfaction with the cleansing agent plays an important role
in subjects' compliance with gut preparation procedure. The study medication NRL0706 is
identical to the PEG+E-containing gut lavage solution commonly used in clinical practice,
with the exception that the flavour has been modified from lemon to orange. This study is to
investigate the tolerability, acceptability, safety and efficacy of a single dose of NRL0706
(MOVIPREP Orange) in subjects without gastrointestinal symptoms undergoing colonoscopy for
colon cancer screening.
Status | Completed |
Enrollment | 120 |
Est. completion date | July 2010 |
Est. primary completion date | July 2010 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 45 Years to 75 Years |
Eligibility |
Inclusion Criteria: - The subject's written informed consent must be obtained prior to inclusion. - Male or female ambulatory subjects aged between 40 to 75 years undergoing a complete colonoscopy for colon cancer screening. - No history of significant gastrointestinal diseases, including gastrointestinal obstruction and perforation or acute symptoms requiring a colonoscopy procedure. - Willing to undergo a colonoscopy for colon cancer screening. - Willing, able and competent to complete the entire procedure and to comply with study instructions. - Females of childbearing potential must employ an adequate method of contraception. Exclusion Criteria: - History of gastric emptying disorders - History of ileus, toxic megacolon, gastrointestinal obstruction and colonic perforation - History of Phenylketonuria - Known Glucose-6-phosphate dehydrogenase deficiency - Known hypersensitivity to macrogol 3350, sodium sulphate or ascorbic acid/ sodium ascorbate - History of colonic resection - Requirement for permanent medication and associated stable serum concentrations (e.g. neuroleptic drugs) - Presence of congestive heart failure (NYHA III + IV) - Acute life-threatening cardiovascular disease - Documented history of severe renal insufficiency - Application of any unlicensed medication within the previous 3 months or participation in any other research study in the last 3 months - Females who are pregnant, nursing or planning a pregnancy. Females of child bearing potential not using reliable methods of contraception - Subjects who the investigator feels would not be compliant with the requirements of the trial |
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
Germany | Wolfgang Fischback | Aschaffenburg |
Lead Sponsor | Collaborator |
---|---|
Norgine |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Overall Acceptance on VAS (100mm) rating | 12 hours | No | |
Secondary | Tolerance on five-point VRS | 12 hours | No | |
Secondary | Taste Evaluation on VAS (100mm) rating | 12 hours | No | |
Secondary | Acceptability rated by compliance, four-point VRS and VAS (100mm) rating | 12 hours | No | |
Secondary | Efficacy on five-grade scale for pre-defined colon areas | 12 hours | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT03457454 -
Reducing Rural Colon Cancer Disparities
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03390907 -
Hybrid APC Assisted EMR for Large Colon Polyps
|
N/A | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT04079478 -
The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
|
||
Active, not recruiting |
NCT04057274 -
Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth
|
N/A | |
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05147545 -
Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects
|
N/A | |
Recruiting |
NCT05026268 -
The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis
|
N/A | |
Not yet recruiting |
NCT03277235 -
Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients
|
N/A | |
Active, not recruiting |
NCT02730702 -
Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
|
||
Active, not recruiting |
NCT02959541 -
PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer
|
N/A | |
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A | |
Recruiting |
NCT02577627 -
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
|
N/A | |
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Recruiting |
NCT02526836 -
Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer
|
Phase 2/Phase 3 |